Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01615029
Brief Title: Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma

First Submitted : June 6, 2012
First Submitted that Met QC Criteria : June 7, 2012
First Posted : June 8, 2012 (Estimate)

Results First Submitted : February 2, 2017
Results First Submitted that Met QC Criteria : March 2, 2017
Results First Posted : April 14, 2017

Certification/Extension First Submitted : September 7, 2016
Certification/Extension First Submitted that Met QC Criteria : October 4, 2016
Certification/Extension First Posted : October 5, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 13, 2018
Last Update Posted : October 12, 2018